Sort by:

select Language:



No Time to Wait: Securing the future from drug-resistant infections

IACG Interagency Coordination Group on Antimicral Resistance, (2019)


UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis. If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who released the report – drug-resistant diseases could cause 10 million deaths each year by 2050 and damage to the economy as catastrophic as the 2008-2009 global financial crisis. By 2030, antimicrobial resistance could force up to 24 million people into extreme poverty.
https://www.who.int/antimicrobial-resistance/inter...


No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance, (2019)


Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
https://www.who.int/antimicrobial-resistance/inter...


Gap analysis: which diseases have treatments on the market or promise in the pipeline?

Access to Medicine Foundation, (2018)


When pharmaceutical companies take action to improve access to medicine, it has the largest impact on their own products. The Access to Medicine Index has identified which products those are – as well as future products still in development – for 20 of the world’s largest research-based pharmaceutical companies
https://accesstomedicinefoundation.org/access-to-m...


Access to Medicines 2018. Fact Sheet

Access to Medicine Foundation, (2018)


The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 2018, jumping ten places to fifth Download the full report from (Large File 22 MB) https://accesstomedicinefoundation.org/media/uploads/downloads/5c8bc9ceb714b_Access%20to%20Medicine%20Index%202018.pdf
https://accesstomedicinefoundation.org/media/uploa...


Medicines Patents, Access and Innovation

Brot für die Welt, (2016)


The growing challenges for people in low and middle-income countries to access new medicines. Analysis 58
https://www.brot-fuer-die-welt.de/fileadmin/mediap...


When the Drugs Don’t Work – Antibiotic Resistance as a Global Development Problem

The Dag Hammarskjöld Foundation and ReAct, (2019)


This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development Goals. The aim of this paper is to inform and stimulate discussions on how to further advance the implementation of 2030 Agenda for Sustainable Development, the Global Action Plan on Antimicrobial Resistance, National Action plans on Antimicrobial Resistance, as well as work within all sectors that affect and are affected by antibiotic resistance
https://www.daghammarskjold.se/publication/when-th...


DETERMINATION DE LA TENEUR EN H2O2 DES SOLUTIONS DE DESINFECTION DES MAINS

Macherey-nagel GmbH & Co , Eds.: Pharm-Ed, (2015)


Test enzymatique sur bandelettes pour le dosage semi-quantitatif de l’H2O2
pharmacie.g2hp.net/files/dlm_uploads/2015/07/h2o2_...


414 hits